Follow-up studies in larger samples adjusting for both Aβ and tau may be done to better clarify the genetic influence on cognition (since the combination of tau and Aβ pathology may be crucial for accelerated cognitive decline). The gene discussed is MAPT; the disease is Mental deterioration.